27
Jan
2027

IGS B.V.

Exhibitor at Pharmapack Europe 2027 stand 4C38, Machinery
About Us

Who we are
As a medical company, you may have a great idea for a device that will give you a competitive edge.

But first you have to find a way to manufacture it according to the strict regulatory requirements for medical devices. IGS GeboJagema can help. For over 80 years, we have been delivering high precision moulds for some of the most successful metered dose inhalers, insulin pens, diagnostic products and other medical devices in the world.

  • Country/Region:
    Netherlands
  • On CPHI since:
    2017
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Consumer Goods
Drug delivery device Supplier/Manufacturer
Machinery and Equipment Supplier/Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Medical Devices
Contact info
Event information
Pharmapack Europe 2027
  • 27 Jan 2027 - 28 Jan 2027
  • Paris Expo, Porte de Versailles - Hall 4 | Paris, France
  • Visit us at stand 4C38, Machinery

Products Featured at Pharmapack Europe 2027

IGS GeboJagema Resources (1)

  • Whitepaper Green Mould

    Enabling sustainable injection moulding. The efforts to combat climate change will havea huge impact on the world economy over thenext decade and beyond. Greenhouse gasemissions must be reduced dramatically. TheEU is aiming at a reduction of 55% by 2030,compared to 1990 levels.* Similar goals arebeing set both by countries and companies inthe rest of the world.To achieve reductions of this magnitude, all sectors andindustries must investigate ways to do more with less. Thisapplies to all companies involved in injection mouldingas well. Traditionally, the critical factors for moulds havebeen accuracy, cycle time, reliability and maintenancefriendliness.But as the world takes steps towards a carbonneutral economy, we expect that energy usage will becomeincreasingly important.